TB Research

Accuracy of QuantiFERON SARS-CoV-2 research use only assay and characterization of the CD4<sup>+</sup> and CD8<sup>+</sup> T cell-SARS-CoV-2 response: comparison with a homemade interferon-γ release assay

Aiello A, Coppola A, Vanini V, Petrone L, Cuzzi G, Salmi A, Altera AMG, Tortorella C, et al. (18 authors)

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022-07

Abstract

Objectives In this study, we aimed to characterize the SARS-CoV-2-specific T cell response detected by the QuantiFERON SARS-CoV-2 research use only assay in terms of accuracy and T cell subsets involved compared with a homemade interferon (IFN)-γ release assay (IGRA). Methods We evaluated T cell response by the standardized QuantiFERON SARS-CoV-2 tubes (antigen [Ag]1 and Ag2) and a homemade IGRA quantifying IFN-γ response to SARS-CoV-2 spike peptides (homemade-IGRA-SPIKE test). We evaluated the T cell subsets mediating the specific response using flow cytometry. Results We prospectively enrolled 66 individuals: COVID-19 or post-COVID-19 subjects and NO-COVID-19-vaccinated subjects, including healthy donors and immunocompromised subjects. The standardized kit detected 62.1% (41/66) of T cell responders. Ag2 tube showed a higher IFN-γ quantitative and qualitative response. Ag1 tube response was mainly mediated by CD4 + T cells; Ag2 tube response was mediated by CD4 + and CD8 + T cells. The homemade-IGRA-SPIKE test detected a higher number of responders (52/66, 78.8%) than the QuantiFERON SARS-CoV-2 assay (P = 0.056). The response was found in both T cell subsets, although a higher magnitude and response rate was observed in the CD4 + T cell subset. Conclusion The QuantiFERON SARS-CoV-2 response is mediated by CD4 + and CD8 + T cells. A lower number of responders is found compared with the homemade-IGRA-SPIKE test, likely because of the different peptide composition.

MeSH terms

  • CD4-Positive T-Lymphocytes
  • CD8-Positive T-Lymphocytes
  • Humans
  • Mycobacterium tuberculosis
  • Tuberculosis
  • Interferon-gamma Release Tests
  • COVID-19
  • SARS-CoV-2